Cluster of Differentiation 44 Promotes Liver Fibrosis and Serves as a Biomarker in Congestive Hepatopathy

被引:28
|
作者
Osawa, Yosuke [1 ,2 ]
Kawai, Hironari [2 ]
Tsunoda, Tomoyuki [3 ]
Komatsu, Haruki [4 ]
Okawara, Miku [2 ]
Tsutsui, Yuriko [2 ]
Yoshida, Yuichi [2 ]
Yoshikawa, Shiori [2 ]
Mori, Taizo [2 ]
Yamazoe, Taiji [2 ]
Yoshio, Sachiyo [2 ]
Oide, Takashi [5 ]
Inui, Ayano [3 ]
Kanto, Tatsuya [2 ]
机构
[1] Int Univ Hlth & Welf Hosp, Dept Gastroenterol, 537-3 Iguchi, Nasushiobara, Tochigi 3292763, Japan
[2] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, 1-7-1 Kohnodai, Ichikawa, Chiba 2728516, Japan
[3] Saiseikai Yokohamashi Tobu Hosp, Dept Pediat Hepatol & Gastroenterol, Yokohama, Kanagawa, Japan
[4] Toho Univ, Sakura Hosp, Dept Pediat, Med Ctr, Sakura, Japan
[5] Natl Ctr Global Hlth & Med, Kohnodai Hosp, Dept Pathol & Lab Med, Ichikawa, Japan
关键词
D O I
10.1002/hep4.1721
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Congestive hepatopathy (CH) with chronic passive congestion is characterized by the progression of liver fibrosis without prominent inflammation and hepatocellular damage. Currently, the lack of reliable biomarkers for liver fibrosis in CH often precludes the clinical management of patients with CH. To explore fibrosis biomarkers, we performed proteome analysis on serum exosomes isolated from patients with CH after the Fontan procedure. Exosomal cluster of differentiation (CD)44 levels were increased in patients with CH compared to healthy volunteers and was accompanied by increases in serum levels of soluble CD44 and CD44 expression in the liver. To address the roles of CD44 in CH, we established a mouse model of chronic liver congestion by partial inferior vena cava ligation (pIVCL) that mimics CH by fibrosis progression with less inflammation and cellular damage. In the pIVCL mice, enhanced CD44 expression in hepatic stellate cells (HSCs) and deposition of its ligand hyaluronan were observed in the liver. Blood levels of soluble CD44 were correlated with liver fibrosis. The blockade of CD44 with specific antibody inhibited liver fibrosis in pIVCL mice and was accompanied by a reduction in S100 calcium-binding protein A4 expression following activation of HSCs. Conclusion: Chronic liver congestion promotes fibrosis through CD44. This identifies CD44 as a novel biomarker and therapeutic target of liver fibrosis in patients with CH.
引用
收藏
页码:1437 / 1447
页数:11
相关论文
共 31 条